Public involvement in guideline development [5]

CMAJ. Canadian Medical Association Journal

Volumn 176, Issue 9, 2007, Pages 1308-1309

  Boivin, Antoine ^a   Légaré, France ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; DRUG INDUSTRY; EVIDENCE BASED MEDICINE; FINANCIAL MANAGEMENT; LETTER; MEDICAL DECISION MAKING; PRACTICE GUIDELINE; QUALITY CONTROL; SOCIAL ASPECT; ADVISORY COMMITTEE; CANADA; CONSUMER ADVOCACY; HUMAN; MANAGEMENT; NOTE; PATIENT PARTICIPATION;

ADVISORY COMMITTEES; CANADA; CONSUMER ADVOCACY; HUMANS; PATIENT PARTICIPATION; POLICY MAKING; PRACTICE GUIDELINES;

EID: 34248216532     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.1060241     Document Type: Letter

References (5)

1. Detsky AS. Sources of bias for authors of clinical practice guidelines [editorial]. CMAJ 2006;175(9): 1033.
2. Cohen J. Are clinical practice guidelines impartial? Int J Technol Assess Health Care 2004;20(4):415-20.
3. Department of Health. The expert patient: a new approach to chronic disease management for the 21st century. London (UK): The Department; 2001.
4. Clinical practice guidelines and conflict of interest. CMAJ 2005;173(11):1297.
5. Crawford MJ, Rutter D, Manley C, et al. Systematic review of involving patients in the planning and development of health care. BMJ 2002;325(7375): 1263.